IP Library Granted Patent US 9,469,857
Granted Patent B2
US 9,469,857 · App. 13/274,637 · Granted Oct 18, 2016

Vectors for directional cloning

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,469,857
App. No.
13/274,637
Granted
Oct 18, 2016
Kind
B2
Abstract

The invention provides vectors and methods for directional cloning.

Claims (17)

1. A method of inducing expression of a DNA sequence of interest in a host cell, comprising contacting a recombinant host cell which is deficient in rhamnose catabolism, and has a recombinant DNA molecule comprising a rhamnose-inducible promoter operably linked to an open reading frame for a heterologous RNA polymerase, with rhamnose and an expression vector comprising a promoter for the heterologous RNA polymerase operably linked to a DNA sequence of interest, so as to induce expression of the DNA sequence of interest, wherein the host cell is an E. coli cell.

2. The method of claim 1 , wherein the DNA sequence of interest is flanked by two restriction enzyme sites, wherein one of the flanking restriction enzyme sites is for a first restriction enzyme which has infrequent restriction sites in cDNAs or open reading frames from at least one species and generates single-strand DNA overhangs, and wherein another flanking restriction enzyme site is for a second restriction enzyme which has infrequent restriction sites in cDNAs or open reading frames from at least one species and generates ends that are not complementary to the overhangs generated by the first restriction enzyme.

3. The method of claim 1 , wherein the expression vector further comprises a transcription terminator sequence.

4. The method of claim 3 , wherein the transcription terminator sequence is that of rrnB.

5. The method of claim 1 , wherein the expression vector is a plasmid.

6. The method of claim 5 , wherein the plasmid further comprises a selectable marker gene.

7. The method of claim 5 , wherein the plasmid further comprises a sequence which specifies a high copy number.

8. The method of any of claim 5 , wherein the plasmid further comprises a sequence which reduces vector multimerization.

9. The method of claim 1 , wherein the host cell does not express one or more rhamnose catalytic genes.

10. The method of claim 1 , wherein the rhamnose-inducible promoter comprises a rhaBAD promoter.

11. The method of claim 1 , wherein the RNA polymerase is a phage RNA polymerase.

12. The method of claim 2 , wherein the expression vector further comprises a transcription terminator sequence that is rrnB.

13. The method of claim 2 , wherein the expression vector is a plasmid comprising a selectable marker gene and a sequence which specifies a high copy number.

14. The method of claim 13 , wherein the plasmid further comprises a sequence which reduces vector multimerization.

15. The method of claim 2 , wherein the rhamnose-inducible promoter comprises a rhaBAD promoter.

16. The method of claim 2 , wherein the RNA polymerase is a phage RNA polymerase.

17. The method of claim 1 , wherein the recombinant host cell is rhaBAD − .

Assignments (3)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: SLATER, MICHAEL R.; HARTNETT, JAMES ROBERT
To: PROMEGA CORPORATION
Reel/Frame 039499/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: SLATER, MICHAEL R.; HARTNETT, JAMES ROBERT
To: PROMEGA CORPORATION
Reel/Frame 039499/0730 →